The Complete Story—GO2 for Lung Cancer and Biomarker Testing

2020-10-06T12:24:49-05:00October 6th, 2020|Hot Topics, Monthly Measure, Science and Research|

Comprehensive biomarker testing identifies what is unique about a lung cancer patient’s cancer, ensuring they receive appropriate treatment. Increasing the use of comprehensive biomarker testing is one of GO2 for Lung Cancer’s key goals. To reach it, we’re using [...]